Below are the earnings highlights for Ligand Pharmaceuticals Inc (LGND):
Earnings: -$31.09 million in Q4 vs. $18.19 million in the same period last year.
EPS: -$1.64 in Q4 vs. $1.03 in the same period last year.
Excluding items, Ligand Pharmaceuticals Inc reported adjusted earnings of $25.22 million or $1.27 per share for the period.
Analysts projected $1.19 per share
Revenue: $42.81 million in Q4 vs. $28.10 million in the same period last year.
For comments and feedback: editorial@rttnews.com